Stephce Mining Machinery Co., ltd.

Welcome to the high-quality mining machines zone!

Contact Now
About Us

Our company is committed to building crushing, industrial grinding, ore processing and green building materials, and provides intelligent solutions and mature supporting products.

  1. Home
  2. > Chipscreen Biosciences Ipo

Chipscreen Biosciences Ipo

Update date: 03-14

Shenzhen chipscreen biosciences has priced its shares at rmb 20.43 2.96 per share in an oversubscribed ipo, the company said iniling. that could translate to rmbillion, or almost 145.

Get Quote
Week In Review 3 China Biopharmas Announce Plans For

Week In Review 3 China Biopharmas Announce Plans For

Shenzhen chipscreen biosciences is expected to be one of the first ipos on shanghais new star board for young technology companies. star.

Jun_5Get Price
Biotech Firm Chipscreen To Raise Cny 102 Million On Star

Biotech Firm Chipscreen To Raise Cny 102 Million On Star

Chipscreen biosciences88321sh filed for an ipo in the new shanghai boursebased marketplace, known as star market, in march 2019. it has passed screening and now is ready to kick off trading with the second batch of tech firms, which is composed of amlogic and friendess technologyn the scitech board.

Apr_5Get Price
Chinese Drugmaker Chipscreens Star Market Ipo Sees

Chinese Drugmaker Chipscreens Star Market Ipo Sees

Shanghaihong kong reuters shenzhen chipscreen biosciences, which plans to list on chinas redhot new tech board, said its newly issued shares were almost 3,000times oversubscribed among.

Dec_6Get Price
Chipscreen Biosciences Us Ltd Hiring Sr Clinical

Chipscreen Biosciences Us Ltd Hiring Sr Clinical

Chipscreen biosciences stock symbol 688321.sh iseading chinabased biotech company, founded in 2001, specializes in discovery and development of novel small molecule treatments.

Jun_5Get Price
Chipscreen Crunchbase Company Profile Amp Funding

Chipscreen Crunchbase Company Profile Amp Funding

Chipscreen isntegrated biotech company specialized in discovery and development of novel small molecule pharmaceuticals. the company has utilized its proprietary chemical genomicsbased discovery platform to successfully developortfolio of clinical and preclinical stage programs inumber of therapeutic areas.

Oct_6Get Price
Shenzhen Chipscreen Biosciences Stock Price, News Amp

Shenzhen Chipscreen Biosciences Stock Price, News Amp

Shenzhen chipscreen biosciences engages in the research, development, and sale of original small molecule drugs. the company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and.

Oct_6Get Price
Chipscreen Sets Pace For Biotech Ipos In Shanghainews

Chipscreen Sets Pace For Biotech Ipos In Shanghainews

Chipscreen became the first biopharma to price its ipo on shanghais star market tuesday, raising rmb1 billion 148.2 million in an upsized offering that signals that the investor exuberance that drove big gains for the first companies.

Nov_5Get Price
Chipscreen Sets Pace For Biotech Ipos In Shanghai

Chipscreen Sets Pace For Biotech Ipos In Shanghai

Biotech industry news, data and analysis. chipscreen sets pace for biotech ipos in shanghai shanghai ipo values chipscreen at 1.2b, opening the door for biopharma listings on the star market.

Apr_5Get Price
Licensing Partner Of Shenzhen Chipscreen Biosciences

Licensing Partner Of Shenzhen Chipscreen Biosciences

Shenzhen chipscreen biosciences chipscreen biosciences, stock symbol 688321.sh was founded in shenzhen in 2001, specializing in the research and development of novel small molecule drugs. within housebuilt proprietary chemical genomicsbased drug discovery and early evaluation platform as its core competitiveness, integrated.

Mar_6Get Price
Chipscreen Sets Pace For Biotech Ipos In Shanghai Biocentury

Chipscreen Sets Pace For Biotech Ipos In Shanghai Biocentury

Chipscreen sets pace for biotech ipos in shanghai shanghai ipo values chipscreen at 1.2b, opening the door for biopharma listings on the star market.

Mar_6Get Price
Shenzhen Chipscreen Raises 148 Million In Nai 500

Shenzhen Chipscreen Raises 148 Million In Nai 500

Shenzhen chipscreen biosciences priced its shanghai star board ipo to raise 148 million at.2 billion valuation, the first china pharma to list on the new exchange. demand for star ipos continues to be offthechart strong chipscreens ipo price reflectse ratio of 468,ecord for the exchange so far. chipscreens block of stock reserved for.

Dec_6Get Price
With Ubs As Bookrunner, Haohai Biotech Goes Public On

With Ubs As Bookrunner, Haohai Biotech Goes Public On

Chipscreen biosciences 688321sh, for instance, raised cny 102.15 million usd 14.45 million through its ipo in early august and then was reportedly trading at over 1,270 times its earnings. selected reports more.

Jan_6Get Price
Chipscreen Crunchbase Company Profile Amp Funding

Chipscreen Crunchbase Company Profile Amp Funding

Phone number 86 75 5269 57330. chipscreen isntegrated biotech company specialized in discovery and development of novel small molecule pharmaceuticals. the company has utilized its proprietary chemical genomicsbased discovery platform to successfully developortfolio of clinical and preclinical stage programs inumber of therapeutic areas.

May_6Get Price
Licensing Partner Of Shenzhen Chipscreen Biosciences

Licensing Partner Of Shenzhen Chipscreen Biosciences

Chidamide isirstinclassbestinclass innovative drug which was discovered and developed originally by shenzhen chipscreen biosciences in china. it is an epigenetic immunomodulator approved.

Jun_5Get Price
Chipscreen Biosciences Overview, News Amp Competitors

Chipscreen Biosciences Overview, News Amp Competitors

View chipscreen biosciences www.chipscreen.com location in guangdong, chinaevenue, industry and description. find related and similar companies as well as.

Oct_6Get Price
Hkex And Star Market How Do New Drug Developers Choose

Hkex And Star Market How Do New Drug Developers Choose

Most of the proceeds of the rmb3.1 billion from ipo were used for research and development of new drugs. by contrast, chipscreen biosciences was valued at less than rmb9 billion on the listing date, with the current market value approximately rmb30 billion.

Feb_5Get Price
Chipscreen And Hisun Reach A Strategic Cooperation

Chipscreen And Hisun Reach A Strategic Cooperation

Chipscreen and hisun reachtrategic cooperation. shenzhen, china, dec. 16, 2020 prnewswire on decem, shenzhen chipscreen biosciences co., ltd. hereinafter referred to as chipscreen biosciences and zhejiang hisun pharmaceutical co., ltd. hereinafter referred to as hisun pharmaceutical.

Aug_6Get Price
Histone Deacetylase 8 Market Business, Trade, Revenue

Histone Deacetylase 8 Market Business, Trade, Revenue

Histone deacetylasearket business, trade, revenue, profit and loss, market players chipscreen biosciences ltd, hitgen ltd, naturewise biotech amp medicals corp 2022 2027 published nov.

Feb_5Get Price
Pharmaboardroom Shanghais Star Board Lures Biotechs

Pharmaboardroom Shanghais Star Board Lures Biotechs

On the stars first day of trading, companies saw their shares jump from between 84 to 400 percent higher than their ipo prices, with an average gain of 140 percent, according to the financial times. shenzhen chipscreen biosciences was among the first to list, issuing 50 million shares at cny20.4 usd2.89 each.

May_6Get Price
Chinese Drugmaker Chipscreens Star Market Ipo Sees

Chinese Drugmaker Chipscreens Star Market Ipo Sees

Shanghaihong kong reuters shenzhen chipscreen biosciences, which plans to list on chinas redhot new tech board, said its newly issued shares were almost 3,000times oversubscribed among retail investors, despite an eyepopping offer pricing of 468times earnings. while the scramble reflectstrong appetite for listings on shanghais nasdaqstyle.

Aug_6Get Price
Shenzhen Chipscreen Biosciences Stock

Shenzhen Chipscreen Biosciences Stock

Shenzhen chipscreen biosciences engages in the research, development, and sale of original small molecule drugs. the company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases.

Jan_6Get Price
Chinese Ipo Breaks New Ground Pricing Shares At Newsmax

Chinese Ipo Breaks New Ground Pricing Shares At Newsmax

Shenzhen chipscreen biosciences co., which was founded in 2001 and focuses on cancer treatments, plans to raise aboutillion yuan 145 million from the offering, about 27 more than its initial target.

Apr_5Get Price
Chipscreens Ipo Earnings Multiple Highest Among Star

Chipscreens Ipo Earnings Multiple Highest Among Star

Chipscreens ipo earnings multiple highest among star market firms so far. by miles goscha aug 2, 2019. aug 7, 2019. share this shanghai stock exchange board. image credit bigstock tk kurikawa chipscreen biosciences shares were 2,956 times oversubscribed among retail investors at rmb20.43 per share, reuters reports. the price.

Mar_6Get Price
Move Over, Hong Kong Shanghais New Endpoints News

Move Over, Hong Kong Shanghais New Endpoints News

Shenzhen chipscreen biosciences has priced its shares at rmb 20.43 2.96 per share in an oversubscribed ipo, the company said iniling. that could translate to rmbillion, or almost 145.

Sep_5Get Price
Chipscreen Received A Phase 1B2 Clinical Trial Of

Chipscreen Received A Phase 1B2 Clinical Trial Of

Shenzhen chipscreen biosciences chipscreen biosciences, stock symbol 688321.sh was founded in shenzhen in 2001, specializing in the research and development of novel small molecule drugs.

Nov_5Get Price
Shenzhen Chipscreen Biosciences

Shenzhen Chipscreen Biosciences

Find the latest shenzhen chipscreen biosciences 688321.ss stock quote, history, news and other vital information to help you with your stock trading and investing.

Sep_5Get Price
Chinese Startups Join Rush To Launch Ipos On Yahoo

Chinese Startups Join Rush To Launch Ipos On Yahoo

The initial public offering ipo applications of shenzhen chipscreen biosciences, anji microelectronics shanghai and suzhou tztek technology will be heard on june 5, the exchange said intatement after the market close on monday, which also suggests the launch of the new board itself is nearing.

Sep_5Get Price
Buy Or Sell Altor Bioscience Stock Pre Ipo Via Equityzen

Buy Or Sell Altor Bioscience Stock Pre Ipo Via Equityzen

Buy or sell altor bioscience stock pre ipo via an equityzen fund. equityzen isarketplace for shares of proven pre ipo tech companies. request access. view more companies. altor bioscience stock. altor bioscience researches and develops immunotherapeutic agents for the treatment of cancer, viral infections and autoimmune diseases.

Jan_6Get Price
Medicilon Assists Chipscreen Biosciences Cs12192 To Be

Medicilon Assists Chipscreen Biosciences Cs12192 To Be

Chipscreen biosciences isioneer in the field of chinas original innovative drugs founded in march 2001 byeam of experienced ph.ds returning from the us. the company adheres to the concept of original, efficiency, safety, and china, focusing on the research and development of innovative drugs in five major areas such as.

Jul_6Get Price
Interview Lu Xianping Chairman And Ceo, Chipscreen

Interview Lu Xianping Chairman And Ceo, Chipscreen

09.07.2018. dr. lu xianping is the founder and now chairman and ceo of one of chinas few truly innovative biotech companies, chipscreen biosciences co. in this exciting interview, he shares the long journey towards the commercialization of their first cancer drug, chidamide, launched in china in 2015, ad now awaiting market approval in japan.

Jul_6Get Price
toTop